BLUELINX HOLDINGS INC (BXC) Fundamental Analysis & Valuation

NYSE:BXC • US09624H2085

59.94 USD
-2.18 (-3.51%)
At close: Mar 6, 2026
59.94 USD
0 (0%)
After Hours: 3/6/2026, 7:03:55 PM

This BXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BXC. BXC was compared to 47 industry peers in the Trading Companies & Distributors industry. While BXC seems to be doing ok healthwise, there are quite some concerns on its profitability. BXC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. BXC Profitability Analysis

1.1 Basic Checks

  • In the past year BXC was profitable.
  • BXC had a positive operating cash flow in the past year.
  • BXC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BXC had a positive operating cash flow.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • BXC's Return On Assets of 0.01% is in line compared to the rest of the industry. BXC outperforms 40.43% of its industry peers.
  • BXC's Return On Equity of 0.04% is on the low side compared to the rest of the industry. BXC is outperformed by 61.70% of its industry peers.
  • With a Return On Invested Capital value of 1.69%, BXC is not doing good in the industry: 65.96% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for BXC is below the industry average of 9.12%.
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROIC 1.69%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • With a Profit Margin value of 0.01%, BXC is not doing good in the industry: 61.70% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of BXC has declined.
  • With a Operating Margin value of 1.02%, BXC is not doing good in the industry: 68.09% of the companies in the same industry are doing better.
  • BXC's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 15.29%, BXC is doing worse than 82.98% of the companies in the same industry.
  • BXC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

6

2. BXC Health Analysis

2.1 Basic Checks

  • BXC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BXC has been reduced compared to 1 year ago.
  • BXC has less shares outstanding than it did 5 years ago.
  • BXC has a worse debt/assets ratio than last year.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.36 indicates that BXC is not in any danger for bankruptcy at the moment.
  • BXC's Altman-Z score of 3.36 is in line compared to the rest of the industry. BXC outperforms 59.57% of its industry peers.
  • The Debt to FCF ratio of BXC is 18.81, which is on the high side as it means it would take BXC, 18.81 years of fcf income to pay off all of its debts.
  • BXC has a Debt to FCF ratio (18.81) which is in line with its industry peers.
  • BXC has a Debt/Equity ratio of 0.96. This is a neutral value indicating BXC is somewhat dependend on debt financing.
  • BXC's Debt to Equity ratio of 0.96 is in line compared to the rest of the industry. BXC outperforms 40.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Altman-Z 3.36
ROIC/WACC0.17
WACC9.92%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.66 indicates that BXC has no problem at all paying its short term obligations.
  • BXC has a better Current ratio (4.66) than 95.74% of its industry peers.
  • A Quick Ratio of 3.12 indicates that BXC has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.12, BXC belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 3.12
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. BXC Growth Analysis

3.1 Past

  • The earnings per share for BXC have decreased strongly by -85.11% in the last year.
  • Measured over the past years, BXC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -35.32% on average per year.
  • The Revenue has been growing slightly by 0.05% in the past year.
  • Measured over the past years, BXC shows a decrease in Revenue. The Revenue has been decreasing by -0.94% on average per year.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%

3.2 Future

  • Based on estimates for the next years, BXC will show a very strong growth in Earnings Per Share. The EPS will grow by 85.45% on average per year.
  • BXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.38% yearly.
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

3

4. BXC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 63.09, the valuation of BXC can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of BXC indicates a slightly more expensive valuation: BXC is more expensive than 63.83% of the companies listed in the same industry.
  • BXC is valuated expensively when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 107.41, the valuation of BXC can be described as expensive.
  • Based on the Price/Forward Earnings ratio, BXC is valued a bit more expensive than the industry average as 65.96% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of BXC to the average of the S&P500 Index (24.57), we can say BXC is valued expensively.
Industry RankSector Rank
PE 63.09
Fwd PE 107.41
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BXC is valued a bit cheaper than 68.09% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BXC is valued cheaper than 85.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.36
EV/EBITDA 10.3
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • BXC's earnings are expected to grow with 85.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.45%
EPS Next 3YN/A

0

5. BXC Dividend Analysis

5.1 Amount

  • No dividends for BXC!.
Industry RankSector Rank
Dividend Yield 0%

BXC Fundamentals: All Metrics, Ratios and Statistics

BLUELINX HOLDINGS INC

NYSE:BXC (3/6/2026, 7:03:55 PM)

After market: 59.94 0 (0%)

59.94

-2.18 (-3.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners99.25%
Inst Owner Change1.62%
Ins Owners2.22%
Ins Owner Change0.01%
Market Cap471.73M
Revenue(TTM)2.95B
Net Income(TTM)219.00K
Analysts77.5
Price Target78.03 (30.18%)
Short Float %6.11%
Short Ratio4.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.66%
Min EPS beat(2)-23.18%
Max EPS beat(2)-10.14%
EPS beat(4)1
Avg EPS beat(4)-14.28%
Min EPS beat(4)-24.67%
Max EPS beat(4)0.88%
EPS beat(8)4
Avg EPS beat(8)9.11%
EPS beat(12)7
Avg EPS beat(12)11.85%
EPS beat(16)10
Avg EPS beat(16)12.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-2.91%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 63.09
Fwd PE 107.41
P/S 0.16
P/FCF 14.36
P/OCF 7.89
P/B 0.76
P/tB 1.02
EV/EBITDA 10.3
EPS(TTM)0.95
EY1.58%
EPS(NY)0.56
Fwd EY0.93%
FCF(TTM)4.17
FCFY6.96%
OCF(TTM)7.6
OCFY12.67%
SpS375.35
BVpS78.44
TBVpS58.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.95
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROCE 2.25%
ROIC 1.69%
ROICexc 2.37%
ROICexgc 2.83%
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
FCFM 1.11%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
ROICexc(3y)7.81%
ROICexc(5y)17.95%
ROICexgc(3y)8.79%
ROICexgc(5y)19.65%
ROCE(3y)6.47%
ROCE(5y)18.75%
ROICexgc growth 3Y-56.47%
ROICexgc growth 5Y-25.31%
ROICexc growth 3Y-57.61%
ROICexc growth 5Y-26.66%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
F-Score5
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Debt/EBITDA 8.51
Cap/Depr 67.49%
Cap/Sales 0.91%
Interest Coverage 0.64
Cash Conversion 85.42%
Profit Quality 15000.5%
Current Ratio 4.66
Quick Ratio 3.12
Altman-Z 3.36
F-Score5
WACC9.92%
ROIC/WACC0.17
Cap/Depr(3y)85.86%
Cap/Depr(5y)87.75%
Cap/Sales(3y)1.05%
Cap/Sales(5y)0.86%
Profit Quality(3y)5219.88%
Profit Quality(5y)3165.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.73%
EBIT growth 3Y-58.02%
EBIT growth 5Y-24.42%
EBIT Next Year80.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.11%
FCF growth 3Y-55.16%
FCF growth 5Y-8.53%
OCF growth 1Y-29.81%
OCF growth 3Y-46.94%
OCF growth 5Y1.68%

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 3 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.